Evidence map›Paper›PMID 29680916›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2018

Letter to the Editor.

Mahdieh Raeeszadeh, Javad Beheshtipour

Abstract readCommentLetter
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 61% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. The Antioxidant Properties of Alfalfa (Oxidative medicine and cellular longevity · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mahdieh RaeeszadehDepartment of Basic Sciences, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran. vet_mr@yahoo.com.
Javad BeheshtipourSanandaj Branch, Islamic Azad University, Sanandaj, Iran.
Islamic Azad University Sanandaj Branch · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to calculated-measure the low-density lipoprotein cholesterol (LDL-C), the Friedewald formula is used. LDL can be calculated by Friedewald formula in this way: total cholesterol (TC) minus high-density lipoprotein (HDL)-cholesterol minus triglycerides (TG)/5 in milligrams per deciliter. In the article entitled "Agmatine protects rat liver from nicotine-induced hepatic damage via antioxidative, antiapoptotic, and antifibrotic pathways" published in the same journal (Vol, 389, pp. 1341-1351), LDL-C has been calculated in this way: LDL-C = TC - [HDL-C - (TG/5)] which is not in accordance with the Friedewald formula and thus the result is false. It may seem that this would be a typo but this could not be the case.

Indexed as

Cholesterol, LDLTriglyceridesAntioxidantsCholesterol, HDLNicotinePhytosterolsAntioxidantsCholesterol, HDLCholesterol, LDLNicotinePhytosterolsTriglyceridesHigh-density lipoprotein cholesterol (HDL-C)Low-density lipoprotein cholesterol (LDL-C)Total cholesterol (TC)

Identifiers

PMID29680916
OpenAlexW4251495374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.